Search Results

The accumulation of transudative fluid in the suprachoroidal space, known as choroidal effusion, is a prevalent and often asymptomatic complication of glaucoma surgery. Choroidal effusions have also been linked with other aetiologies, including infections, inflammatory diseases, medications and other ocular surgeries.1,2 While choroidal effusions do not typically lead to long-term complications, if particularly large or persistent, […]

Welcome to the latest edition of touchREVIEWS in Ophthalmology, and my first as the journal’s Editor-in-Chief. In this issue, we are delighted to present a series of compelling articles providing insights into some of the cutting-edge developments in this diverse and ever-evolving field. Dhanashree Ratra and Aashna Ratra open the edition with the first in […]

Retinal pharmacotherapy encompasses various drug delivery routes that offer potential avenues for effective treatment (Figure 1). Among these, intravitreal injections have emerged as the predominant method employed in clinical practice.1 They have established themselves as the primary approach for administering anti-vascular endothelial growth factor (anti-VEGF) therapy, serving as the frontline treatment for neovascular age-related macular degeneration […]

Welcome to the latest edition of touchREVIEWS in Ophthalmology. In this edition, we feature a range of reviews and editorials on various diseases, including glaucoma and ocular surface disease, to name but a few, discussing improvements in our understanding and novel treatment options for ophthalmological conditions. We begin this issue with an expert interview with […]

Corticosteroids are the best choice for treating various ocular conditions affecting the anterior and posterior segments of the eye.1 Currently, different routes are available for ocular administration of corticosteroids. Topical application to the eye is the route of choice when targeting diseases affecting the ocular surface and anterior segment, whereas posterior segment conditions may require periocular, […]

An overview and the mechanism of action of RGX-314 is discussed in this touchOPHTHALMOLOGY interview with Prof. Arshad Khanani (Sierra Eye Associates, Reno, NV, USA) as well as the limitations of anti-VEGF therapy for neovascular AMD. The presentation entitled ‘Suprachoroidal Delivery of RGX-314 Gene Therapy for Neovascular AMD: The Phase II AAVIATE™ Study’ was presented […]

The clinical outcomes of the AAVIATE study (NCT04514653) is discussed in this touchOPHTHALMOLOGY interview with Prof. Arshad Khanani (Sierra Eye Associates, Reno, NV, USA).  RGX-314 is being developed as a potential one-time treatment for neovascular AMD as current anti-VEGF therapies require life-long intraocular injections to maintain efficacy. Due to the burden of treatment, patients often […]

Welcome to the latest edition of US Ophthalmic Review, which aims to review topical subjects in the field of ophthalmology. This edition features a wide range of articles that evaluate current practices and research, as well as discussing future directions and innovations that directly affect ophthalmologists. We begin with an article on corneal cross-linking (CXL). The […]